Circulating tissue factor antigen levels after LPS administration to healthy individuals
| Time point (h) . | TF antigen (pg/mL) . |
|---|---|
| −0.5 | 165 ± 33 |
| +0.5 | 146 ± 23 |
| +1 | 163 ± 38 |
| +2 | 170 ± 27 |
| +3 | 179 ± 28 |
| +4 | 162 ± 13 |
| +6 | 127 ± 9 |
| +8 | 157 ± 23 |
| +24 | 160 ± 26 |
| Time point (h) . | TF antigen (pg/mL) . |
|---|---|
| −0.5 | 165 ± 33 |
| +0.5 | 146 ± 23 |
| +1 | 163 ± 38 |
| +2 | 170 ± 27 |
| +3 | 179 ± 28 |
| +4 | 162 ± 13 |
| +6 | 127 ± 9 |
| +8 | 157 ± 23 |
| +24 | 160 ± 26 |
Data shown are mean ± SEM. Time points refer to intravenous LPS injection (t = 0). LPS, lipopolysaccharide; TF, tissue factor.